Pharma Marketing Service (PMS) is the online version of the weekly
information and research service for pharmaceutical professionals.
Pharma Marketing Service focuses on all the topics needed in
pharmaceutical marketing including advertising, public relations and
sales promotion. News is reported on companies, markets, products,
health policy, medical science and pharmacology. Used by
professionals in the pharmaceutical industry as well as in research
institutes, trade associations, advertising agencies and
consultancies, DPMS provides valuable data for market development
and companies' financial news.
DPMS concentrates on news from Western Europe (which accounts for
about 50% of the database), USA (25%), Eastern Europe (15%) and
Japan (5%). Simple in structure, DPMS documents contain the full
text of the articles from the hard copy together with titles,
information categories and descriptors to facilitate subject
searches. The database is in German.
Use DPMS to answer questions like:
- what are the laws on TV advertising for pharmaceuticals?
- what is the state of the Irish pharmaceutical industry?
- how did Merck (Darmstadt) perform in 1993?
- are there any clinical studies of an Organon product which
reduces the neurotoxic side effects of cisplatin?
Sources:
A team of editors draws news from 200 international newpapers and
scientific and economic journals. In addition, news from the
producer's own correspondents, and news from press releases of
pharmaceutical companies, government agencies and national and
international organizations is included.
Accession number & update
PHARMA MARKETING SERVICE 89206221 900528.
Title
Du Pont erhaelt FDA-Zulassung fuer Transplant-Konservierungs-
mittel Viaspan.
Source
presseinfo 16.
Length
1029 Zeichen , ergibt ca. 1 Bildschirmseite.
Publication date
890514.
Subject category
F Firmen.
Classification codes
F-D-89-20-69.
Descriptors
Du-Pont-Co.
Text
Das von Du Pont entwickelte Transplant-Konservierungsmittel
Viaspan hat in den USA die Zulassung erhalten. Die neue Loesung
verlaengert nach Angaben des Unternehmen die Zeitspanne, die bei
der Uebertragung einer Leber oder Bauchspeicheldruese zwischen
der Entnahme beim Spender und der Implantation beim Empfaenger
eingehalten werden muss, auf das Dreifache. Diese Spanne betrug
bisher acht Stunden. Die Loesung koenne auch die Erhaltungsdauer
bei zu transplantierenden Nieren auf bis zu 40 Stunden erweitern.
In den USA und in Europa wird Viaspan ab Juni erhaeltlich sein.
Zur Zeit fuehrt Du Pont weitere Forschungen durch, um zu
ermitteln, ob die Loesung auch fuer andere Spenderorgane
eingesetzt werden kann.
Label/description Example
AN Accession number 1_: 89206221
& update - see Limit options -
TI Title 2_: VIASPAN.TI.
SO Source 3_: PRESSEINFO
LE Length - display only -
DT Publication date
DATE= Publication date YYYYMMDD 4_: DATE=19980726
MONTH= Publication month YYYYMM 5_: MONTH=199807
YEAR= Publication year YYYY 6_: YEAR=1998
SC Subject category 7_: F.SC.
8_: SC=F
CC Classification codes 9_: F-D$
DE Descriptors 10_: DU-PONT$
11_: DU ADJ PONT.DE.
TX Text 12_: TRANSPLANT WITH
KONSERV$.
1_: DU ADJ PONT
DATE Publication date YYYYMMDD 2_: ..L 1 DATE<1998072
MONTH Publication month YYYYMM 3_: ..L 1 MONTH EQ 199807
YEAR Publication year YYYY 4_: ..L 1 YEAR WL 1998,1999
UMONTH Update month YYYYMM 5_: ..L 1 UMONTH>199906.
By paragraph - title, text _: ..P TI, TX(1,5) 1-4
SHORT AN TI LE DT SC
MEDIUM AN TI DT SC TX
LONG AN TI SO DT DE CC SC TX
FREE AN TI LE DT SC CC DE
_: ..P SHORT 1,8,10.
Search Options:
..SET MEDWORD ON can be selected in DPMS.
Back to the Datasheet Index Page
© 2008 Dialog DataStar
|